Soluble Fibrin Monomer
Use
The Soluble Fibrin Monomer test is used to assess the presence of soluble fibrin monomers in the plasma, which can indicate ongoing coagulation activation. This test is important in evaluating patients who may be at risk of thrombotic disorders, as the presence of soluble fibrin monomer complexes can signal active clotting processes within the bloodstream.
Special Instructions
Critical frozen specimen transport is required. Separate specimens must be submitted when multiple tests are ordered to prevent cross-contamination and ensure the integrity of the results.
Limitations
The test results may be affected by improper specimen collection or handling, which can lead to false-positive results. Particularly, activation of specimen due to poor venipuncture technique is a known source of diagnostic confusion. Hemolysis, clotting, or use of incorrect containers such as glass vials can cause specimen rejection.
New York Approved
Methodology
Immunoassay (Other)
Biomarkers
LOINC Codes
- 40702-3
- 40702-3
Result Turnaround Time
1-6 days
Related Documents
For more information, please review the documents below
Specimen
Plasma
Volume
1.5 mL Platelet-poor plasma
Minimum Volume
1 mL
Container
Light-blue top (3.2% sodium citrate), Plastic vial
Collection Instructions
Centrifuge at 1700 x g for 15 minutes. Aliquot 1.5 mL platelet-poor plasma into the plastic vial making sure not to disturb the buffy coat. Send frozen.
Storage Instructions
Send frozen.
Causes for Rejection
Hemolysis, Clotted specimens, Glass vials, Serum, EDTA plasma
Stability Requirements
| Temperature | Period |
|---|---|
| Frozen | 14 days |